GENE ONLINE|News &
Opinion
Blog

Eisai
Editors' Picks Healthcare Industrybiotechbiopharma
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Technology Alzheimer's DiseaseEisai
Revolutionary Wristband Sensor Technology Predicts Alzheimer’s Risk
2024-01-04
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
Trials & Approvals Alzheimer's DrugFDA Approval
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
Editors' Picks Singapore
GeneOnline’s Weekly News Highlights: July 3-7
2023-07-10
Trials & Approvals KeytrudaLenvima
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Trials & Approvals Alzheimer's Disease
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
Trials & Approvals Eisai
Eisai Touts Lenvima Efficacy In Thyroid Cancer Study
2022-10-24
Trials & Approvals Biogen
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Trials & Approvals Liver Cancer
Merck and Eisai Come Up Short in the Clinic with Liver Cancer Combination Therapy
2022-08-04
Trials & Approvals FDA
Eisai and Biogen’s New Alzheimer’s Drug to Receive FDA Decision by January
2022-07-06
Regulatory Alzheimer's Drug
Eisai to File Another Biogen-Partnered Alzheimer’s Drug After Confidence Hit
2022-05-10
Trials & Approvals Alzheimer's Disease
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
Trials & Approvals AHEAD 3-45
FDA Grants Breakthrough Status to Two Experimental Alzheimer’s Drugs While Pushback Over Aduhelm’s Approval Still Rages On
2021-06-25
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
1 2 3
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top